| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $167.7M | — | -7.5% |
| Cost of Revenue | $58.4M | — | -5.9% |
| Gross Profit | $109.3M | — | -8.4% |
| R&D Expense | $11.4M | — | +12.0% |
| SG&A Expense | $45.8M | — | -12.3% |
| Operating Income | $4.1M | — | +233.8% |
| Pre-tax Income | -$1.5M | — | +88.3% |
| Income Tax | -$6.0M | — | -109.5% |
| Net Income | $4.5M | — | +147.2% |
| EPS (Basic) | $0.10 | — | +145.5% |
| EPS (Diluted) | $0.10 | — | +145.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.0M | -26.0% | -27.7% |
| Accounts Receivable | $147.1M | +7.8% | +5.1% |
| Current Assets | $200.8M | +12.2% | -1.0% |
| Total Assets | $693.7M | +0.7% | -1.4% |
| Current Liabilities | $163.3M | -9.1% | -13.8% |
| Long-term Debt | $258.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.5M | — | +114.1% |
| Investing Cash Flow | -$6.9M | — | +4.2% |
| Financing Cash Flow | $2.6M | — | -79.0% |
| -13.5% |
| Stockholders' Equity | $225.4M | +3.3% | +16.7% |